• Published by, 26th Oct 2018 in category Hospitality / Tourism / Retail in English

    Just four months after acquiring full control of luxury etailer Yoox Net-a-Porter (YNAP), luxury goods company Richemont has struck up a strategic relationship with Chinese internet giant Alibaba. In terms of the deal, announced on Friday, Richemont and Alibaba have established a joint venture that will launch two mobile apps for YNAP’s two brands Net-A-Porter and Mr Porter, for consumers in China. Alibaba will provide technology infrastructure, marketing, payments, logistics, and other technical support to the JV. In addition, the JV will launch Net-A-Porter and Mr Porter online stores on Alibaba’s Tmall Luxury Pavilion (sic), a platform dedicated to the world’s leading luxury brands. Launched in 2017, this platform aims to create the same brand exclusivity and tailored shopping experience that customers shopping offline typically enjoy. Richemont chairman Johann Rupert is keenly aware of the potential of the internet for the sale of luxury brands – online sales are one of the industry’s fastest growth drivers. He has placed YNAP at the centre of the company’s efforts to ramp up its e-commerce operations and attract younger shoppers. It operates sales platforms for 40 luxury labels as well as multi-brand online stores Net-a-Porter, Mr Porter, The Outnet and Yoox. In June, shortly after acquiring control of YNAP, Richemont announced its delisting from the Milan Stock Exchange.

  • Published by, 24th Oct 2018 in category Business in English

    From October 22nd to 23rd, 2018, SZSE respectively held the V-Next platform cross-border investing and financing matchmaking events in Jerusalem, Israel, and Geneva, Switzerland. President & CEO Wang Jianjun of SZSE and representatives from the National Innovation Bureau of Israel, investment institutions and SMEs of Israel and Switzerland participated in the relevant activities. At the events, nine Israeli technical innovation companies and six Swiss SMEs conducted cross-border roadshows to Chinese investors through the V-Next platform. Mr. Wang said that as China's reform and opening up continues to deepen, Chinese companies continue to "go out to the world" and put forward new and higher requirements for cross-border financial services. As the core institution of the capital market, SZSE plays an important role in the formation of innovative capital and cross-border capital ties. The V-Next platform is a cross-border extension of SZSE's innovative capital formation ecosystem and has gathered more than 6,500 technical ventures and more than 4900 investment institutions in China.

  • Published by, 19th Oct 2018 in category Bilateral Relations in English

    Through the Sino-Swiss Shenzhen Hub, the GGBa and Invest Shenzhen aim at stimulating and facilitating FDIs between two of the world’s most dynamic regions. The GGBa has added to its established presence in China by launching the Sino-Swiss Shenzhen Hub. A joint initiative of the GGBa and Invest Shenzhen, the new platform intends to showcase Western Switzerland and the region surrounding the Pearl River Delta as a portal for Chinese and Swiss companies interested in expanding their footprint in another continent. “Western Switzerland is the gateway for Shenzhen-based companies willing to start operations in Europe,” said Thomas Bohn, Executive Director of the GGBa, to Shenzhen TV. Formerly a small fishing village in the vicinity of Hong Kong, Shenzhen has experienced unprecedented development over the past 30 years, under the leadership of Deng Xiaoping and his policy of economic openness. Today, the city is known as China’s Silicon Valley, with a proliferation of high-potential technology startups and the presence of industry giants such as DJI, ZTE, Huawei or Tencent. Western Switzerland and the region surrounding Shenzhen share many common points ; both boast a dynamic business base, leading companies, and cutting-edge know-how in the ICT, health, finance, artificial intelligence, robotics and precision industry sectors.


  • Published by, 18th Oct 2018 in category Business in English

    Swiss watchmaker Patek Philippe is seeing good demand across the world, its president told Reuters on Thursday, playing down industry concerns about a potential slowdown in top luxury goods buyer China. Data earlier in the day showed Swiss watch exports fell 7% in September, their first decline since April last year and adding to jitters that have hit luxury goods stocks. But Patek Philippe, which has been making watches in Geneva since 1839, remains upbeat. “All of our markets did well this year, we’re quite satisfied. An exhibition we organised in the United States boosted the brand there, Europe is also still doing well,” Thierry Stern said in an interview at the firm’s headquarters. “Domestic Chinese demand is rising steadily, we sell more watches every month. Not the very complicated pieces because taxes remain high, but the core collections,” he added. Stern said the Chinese were likely buying more at home due to worries about issues such as stricter border controls.

  • Published by, 08th Oct 2018 in category Bilateral Relations in English

    The Swiss Incubator, a platform dedicated to high-tech startups which was initiated by the Embassy of Switzerland in China, drew a successful conclusion on 19 September on the sideline of the World Economic Forum's 12th Annual Meeting of the New Champions in Tianjin (WEF Tianjin). Attended by Swiss and Chinese government officials, 10 handpicked fast-growing high-tech companies from Switzerland presented their advanced technologies and potentials of their products. They showcased Switzerland's global leadership in bottom-up innovation at the nexus of industry, technology, art and design. The event, for the third time hosted during the WEF, is expected to strengthen the link between Switzerland and the WEF. The 10 startups are engaged in different industries, in which Switzerland has leading advantages, including biotech, pharmaceuticals, electronics, mechanics, and clean technology. The startups are also in China for a 10-day road show within the framework of Venture Leaders China 2018, organized by Swissnex China and Venture lab. With business workshops, investor meetings and public events in Hong Kong, Shenzhen, Shanghai, Beijing and Tianjin. The road show offers the startups unparalleled exposure and insight into the Chinese market, along with learning about business opportunities, how corporate affairs work, pitching to investors and getting insights from experts. "Switzerland is being known as the leading country globally in terms of innovation and technology. Originating from Switzerland, they have the strong desire to go abroad, especially China for big markets and collaboration opportunities," said the Swiss Ambassador to China Jean-Jacques de Dardel.


  • Published by, 02nd Oct 2018 in category Engineering / Manufacturing in English

    Novartis has paid USD 40 million for a 9% stake in Cellular Biomedicine Group (CBMG), a Shanghai-based firm which will manufacture CAR-T cell therapy Kymriah for the China market. Under terms of the deal, CBMG will take responsibility for the manufacture of the chimeric antigen receptor (CAR) T-cell therapy Kymriah (tisagenlecleucel) from its facility in Shanghai, China, on behalf of Novartis entity Beijing Novartis Pharma for supply in China. “Aligned with our global supply and regulatory strategy, Novartis actively has been pursuing options for additional manufacturing capacity to help meet global demand for Kymriah,” Julie Masow, a spokesperson from the Swiss pharma giant told BioProcess Insider. “CBMG came to our attention as we were looking for a collaborator that would be capable of helping us to manufacture and supply Kymriah to patients in China, as local regulations require that the product be manufactured in China.” Previously, Chinese drug firms were not allowed to resort to contract manufacturing organizations (CMOs), so relied almost entirely on overseas manufacturers. But in 2015, the Chinese government implemented the marketing authorization holder (MAH) system completely rewriting regulations governing the way that pharmaceuticals, are manufactured, researched, clinically developed, and reviewed. While these continue to evolve, they demand biopharmaceutical CMOs to operate locally.

  • Published by, 28th Sep 2018 in category Business in English

    CNNMoney Switzerland debuts a special series about China and presents its new editorial partnership with the Swiss global network swissnex. CNNMoney Switzerland brought the latest on what Swiss companies need to know when they do business in China. “China: Dealing with the New Superpower” was about market access, the consequences of the trade war with the U.S., and China's new ambitions in specific sectors, including its capabilities to shift to an innovation-driven economy. With a dedicated team there, including Olivia Chang, Joël Espi, and Frédéric Lelièvre, CNNMoney Switzerland featured special coverage of the World Economic Forum meeting in Tianjin. It also produced some content from the CNN International studio in Hong Kong. “China is a very important market for Switzerland and Swiss companies, and we want to take a close look at how the new superpower changes the international political and economic landscape,” says Editor in Chief Urs Gredig. CNNMoney Switzerland announced the launch of a special monthly program with swissnex, the Swiss global network connecting the dots in education, research, and innovation. Together they will inform their communities and viewers on what Swiss innovators and entrepreneurs need to know from the fastest major markets around the globe. “Scientific and technological innovation and its impact on society concerns us all,” says Christian Simm, CEO of swissnex Boston. In collaboration with CNNMoney Switzerland and from five of the world’s most innovative regions, the swissnex network is delighted to share the dreams, challenges and achievements of the researchers, creators, and entrepreneurs who are inventing the future.”

  • Published by, 26th Sep 2018 in category Bilateral Relations in Chinese

    The first China-Europe Talent Forum was jointly hosted in Zurich, Switzerland, on 25 September by the Chinese Embassy in Switzerland and the Swiss Adecco Group. The forum gathered more than 100 senior executives from over 40 Chinese and European companies to exchange their views on three topics: European labour market and its laws and regulations, international talent acquisition, and staff management and training. Geng Wenbing, Chinese ambassador to Switzerland, said at the forum that since the beginning of the 21st century, talent has become the key factor for the development of all countries and business. After 40 years of reform and opening up, China's economy, now shifting from high-speed growth to high-quality development, is at a key phase of changing patterns, optimizing economic structure, and transforming growth momentum. An economy driven by innovation is, after all, one driven by talent, which is why the Chinese market has a huge demand for high-level talents, Geng said. He added that the Chinese government has always attached great importance to the work related to talent, including the international cooperation in this field. China and Europe are the world's two major economies, showing a broad prospect for cooperation in the area. The forum aims to promote the exchange and integration of all talent by building an open, pragmatic and future-oriented Sino-European talent exchange platform that will help Chinese enterprises operating in Europe actively participate in international cooperation, the ambassador concluded.

  • Published by markets.businessinsider., 10th Sep 2018 in category Engineering / Manufacturing in English

    On 5 September, GF Machining Solutions held a ground-breaking ceremony for its new Phase II project in Changzhou National Hi-Tech District, with Liang Yibo, vice mayor of Changzhou; Chen Zhengchun, director of the Administration Committee of Changzhou National Hi-Tech District and director of Xinbei District; and Xu Yawei, vice director of Xinbei District in attendance. The USD 48 million, 32,000-square-meter facility, built on a 5.14 hectare plot of land, will be equipped with a manufacturing workshop and offices. The main focus will be the research, development and production of high-end machine tools, with the aim of establishing GF Machining Solutions as the world-class manufacturing base and R&D center for such tools. The project will help promote technical innovation across the district's equipment manufacturing sector, as well as attract the best companies from the upstream and downstream segments of the industry to set up operations locally, setting in motion the development of the district's equipment manufacturing industry chain. Changzhou GF Machining Solutions is a subsidiary of Switzerland-based Georg Fischer. Founded in 1802, Georg Fischer is one of the world's leading industrial groups, with operations in over 140 countries and regions. The group has more than 15,800 employees worldwide and generated sales of CHF 4.2 billion (approx. USD 4.33 billion) in 2017.

  • Published by, 10th Sep 2018 in category Hospitality / Tourism / Retail in English

    Cartier maker Richemont said sales of its watches and jewellery rose 10% in the five months to 31 August, helped by strong demand in Asia Pacific and the Americas. Swiss watchmakers have seen sales rebound strongly after a severe downturn, but some investors now fear Chinese luxury demand could have peaked and rising trade tensions could take their toll. "Hong Kong, Korea and Macau all generated double digit increases while China showed good growth," the world's second biggest luxury goods group said in a statement released ahead of its annual general meeting in Geneva. It did not provide an outlook for the rest of the year. Sales in constant currency rose 10% in the period, while sales at actual exchange rates were up 7%, Richemont said, which on Monday also appointed Jerome Lambert as chief executive. Including recently acquired Yoox Net-a-Porter (YNAP) and, sales were up 25% at constant exchange rates and 22% at actual rates.